Clinical Trial UCI-17-48

Title

A Multinational Phase III, Randomized, Open-label, Parallelgroup Study to Evaluate the Safety and Efficacy of Relugolix in Men with Advanced Prostate Cancer (HERO)

Principal Investigator

Edward Uchio

Details

Learn More

For more information about cancer clinical trials at the Chao Family Comprehensive Cancer Center, please call toll-free: 877.UC.STUDY (877.827.8839) or email ucstudy@uci.edu